pentobarbital will decrease the extent or effect of eltrombopag by influencing hepatic enzyme CYP2C9/10 metabolism. Use Warning/Monitor.Contraindicated (1)pentobarbital will decrease the level or outcome of cobimetinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration. Solid or reasonable CYP3